1-((2R,3R,4S,5S)-5-((S)-1-((2R,3R,4S,5R)-5-(aminomethyl)-3,4-dihydroxytetrahydrofuran-2-yloxy)prop-2-ynyl)-3,4-dihydroxytetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

ID: ALA4556639

Chembl Id: CHEMBL4556639

PubChem CID: 155556933

Max Phase: Preclinical

Molecular Formula: C16H21N3O9

Molecular Weight: 399.36

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  C#C[C@H](O[C@@H]1O[C@H](CN)[C@@H](O)[C@H]1O)[C@H]1O[C@@H](n2ccc(=O)[nH]c2=O)[C@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C16H21N3O9/c1-2-6(26-15-12(24)9(21)7(5-17)27-15)13-10(22)11(23)14(28-13)19-4-3-8(20)18-16(19)25/h1,3-4,6-7,9-15,21-24H,5,17H2,(H,18,20,25)/t6-,7+,9+,10-,11+,12+,13+,14+,15+/m0/s1

Standard InChI Key:  ZMPJDHGJNDQVLQ-LNBGRKRMSA-N

Alternative Forms

  1. Parent:

    ALA4556639

    ---

Associated Targets(non-human)

mraY Phospho-N-acetylmuramoyl-pentapeptide-transferase (67 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
mraY Phospho-N-acetylmuramoyl-pentapeptide-transferase (78 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mycobacteroides abscessus (2066 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 399.36Molecular Weight (Monoisotopic): 399.1278AlogP: -4.42#Rotatable Bonds: 5
Polar Surface Area: 189.49Molecular Species: BASEHBA: 11HBD: 6
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 7#RO5 Violations (Lipinski): 2
CX Acidic pKa: 9.70CX Basic pKa: 8.75CX LogP: -3.66CX LogD: -4.78
Aromatic Rings: 1Heavy Atoms: 28QED Weighted: 0.26Np Likeness Score: 1.42

References

1. Patel B, Ryan P, Makwana V, Zunk M, Rudrawar S, Grant G..  (2019)  Caprazamycins: Promising lead structures acting on a novel antibacterial target MraY.,  171  [PMID:30933853] [10.1016/j.ejmech.2019.01.071]
2. Kusaka S, Yamamoto K, Shinohara M, Minato Y, Ichikawa S..  (2022)  Design, synthesis and conformation-activity relationship analysis of LNA/BNA-type 5'-O-aminoribosyluridine as MraY inhibitors.,  65  [PMID:35500521] [10.1016/j.bmc.2022.116744]
3. Okamoto K, Ishikawa A, Okawa R, Yamamoto K, Sato T, Yokota SI, Chiba K, Ichikawa S..  (2021)  Design, synthesis and biological evaluation of simplified analogues of MraY inhibitory natural product with rigid scaffold.,  55  [PMID:35016115] [10.1016/j.bmc.2021.116556]

Source